Skip to content

Evaluation of the effect of intraperitoneal injection of Bupivacain 0.5% in post operation nausea and vomiting in laparascopic cholecystectomy

Evaluation of the effect of intraperitoneal injection of Bupivacain0.5% in post operation nausea and vomiting in laparascopic cholecystectomy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201110287928N1
Enrollment
50
Registered
2012-04-22
Start date
2009-07-26
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nausea and vomiting resolve after laparscopic cholecystectomy. Postcholecystectomy syndrome

Interventions

Intervention 1: intervention group received, 0.5mg/kg intraperitoneal Bupivacain 0.5 % after Laparascopic cholecystectomy. Intervention 2: control group received 0.5 cc/kg , normal salin after La
Treatment - Drugs
intervention group received, 0.5mg/kg intraperitoneal Bupivacain 0.5 % after Laparascopic cholecystectomy
control group received 0.5 cc/kg , normal salin after Laparascopic cholecystectomy

Sponsors

Ahvaz Jundishapur University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: 20-60 years old without diabetes mellitus, hypertension, congenital or acquired heart dieses exclusion critreria: duration of surgery more than 2 hours, another operation at the same time, complication in or after operation

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

MeasureTime frame
Vomiting. Timepoint: 1hrs,2hrs,6hrs,12hrs after surgery. Method of measurement: VAS.

Primary

MeasureTime frame
Nausea. Timepoint: 1hrs,2hrs,6hrs,12hrs after surgery. Method of measurement: VAS.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Reza Akhond zade

Ahvaz Jundishapur University of Medical Sciences

rezaakh@hotmail.com6193673166 -00986112222114

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026